Where is the growing science and its link to disease leading us in terms of new treatments for patients with unresolved chronic conditions?

Will progress in therapies that promise a genetic cure for devastating rare diseases lead to similar innovations in patient access to these highcost, high-touch treatments?

Can the foundational biologic understandings now being brought to cancer care be leveraged to secure a targeted, more personalized approach to other conditions?